Charles River Laboratories, a Wilmington, Massachusetts-headquartered contract research organization (CRO), has added a new, 73,000-square-foot facility in Wayne, Pennsylvania to expand its biologics testing services.

Charles River announced several expansions to its biologics testing solutions infrastructure to support the characterization, development, and release of biologics and biosimilars. The new facility will more than double the laboratory space available at Charles River’s existing facilities in Malvern and King of Prussia, Pennsylvania.

Certain laboratory operations conducted at Charles River’s Malvern and King of Prussia sites are expected to begin to move to the new Wayne facility early in the third quarter of 2018. The formal transfer of assays will be done in phases, and during the transition, both the Malvern and King of Prussia facilities will remain fully operational.

Source: Charles River Laboratories